Second round of abstract submission: August 06, 2021 Early bird registration: August 09, 2021
6th International Conference on

VaccinesResearch & Development

Register

Speakers

Kathleen Maletic Neuzil
Kathleen Maletic Neuzil
Director, Center for Vaccine Development and Global Health, UMSOM
Andrea Carfi
Andrea Carfi
VP & Head of Research, Infectious Disease, Moderna Inc.
Dan H. Barouch
Dan H. Barouch
Director, Center for Virology and Vaccine Research, BIDMC
Julie A. Ake
Julie A. Ake
Director, US Military HIV Research Program
Pei-Yong Shi
Pei-Yong Shi
John Sealy Distinguished Chair in Innovations in Molecular Biology UTMB at Galveston
Derek T. O’ Hagan
Derek T. O' Hagan
Senior Advisor Vaccines R&D
GSK
Marcus A. Horwitz
Marcus A. Horwitz
Professor, UCLA School of Medicine
Nathaniel R. Landau
Nathaniel R. Landau
Professor, Department of Microbiology, NYU Grossman School of Medicine

Vaccines R&D Previous Events

Submit your abstract

Flexible Registration
Swap In-Person or Virtual Anytime

August 09, 2021

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Rino Rappuoli, Chief Scientist & Head of External Research and Development, GSK Vaccines

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Nathalie Garçon, Chief Executive and Scientific Officer, IRT BIOASTER

What Speakers Say

It was really a great meeting this year, with an impressive roster of speakers the day I attended.

Jay A. Berzofsky, Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

What Speakers Say

Congratulations. You have really made progress, and the meeting is getting better each time

Stephen L. Hoffman, Chief Executive and Scientific Officer, Sanaria Inc.

What Speakers Say

Thank you, I learned much at this meeting and made many new contacts

Michael G. Hanna, Founder and Chairman Emeritus, Vaccinogen Inc.

What Speakers Say

The meeting is getting better every year. Great work in organizing the speaker line

Farshad Guirakhoo, Chief Scientific Officer, GeoVax, Inc.

What Speakers Say

The first one was pretty bad but they have gotten progressively better. I thought Vaccine R&D2018 in Baltimore was well worth attending

Andrew Lees, Scientific Director, Owner, Fina BioSolutions LLC

/

Sponsors & Exhibitors

2014

Year of Foundation

765

Speakers

2500+

Attendees

150

Happy Clients